$3.2 million NIH grant aims to correct diagnostic errors for breast cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In a new UCLA-led study, funded by a $3.2 million NCI grant, researchers will examine how perception and cognition interact in the interpretation of breast biopsy images. The aim is to improve physicians’ diagnostic skills and accuracy.

Joann Elmore, a UCLA Jonsson Comprehensive Cancer Center member and professor of medicine in the David Geffen School of Medicine at UCLA, is leading the five-year project which will study diagnostic errors made by residents in training as well as experienced pathologists.

“Pathologists want to be better at their job and find every suspicious lesion, but when they do make errors, it can be hard to know why,” said Elmore, who is also director of the UCLA National Clinician Scholars Program. “This project will use advanced eye-tracking techniques that measure exactly where the pathologist was looking during each case so that we can determine what is leading to diagnostic errors.”

Elmore’s previous research has identified high levels of disagreement and errors among physicians in the diagnosis of cancer.

YOU MAY BE INTERESTED IN

In this episode of The Cancer Letter Podcast, Paul Goldberg, editor and publisher of The Cancer Letter, Jacquelyn Cobb, managing editor, discuss the Sept. 23 meeting of the FDA Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee, during which the panel voted in favor of Galleri, the multi-cancer detection test from GRAIL Inc., to become the first multi-cancer detection test to receive regulatory approval.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login